HMX2

gene
On this page

Also known as NKX5-2

Summary

HMX2 (H6 family homeobox 2, HGNC:5018) is a protein-coding gene on chromosome 10q26.13, encoding Homeobox protein HMX2 (A2RU54). Transcription factor involved in specification of neuronal cell types and which is required for inner ear and hypothalamus development.

The protein encoded by this gene is a member of the NKL homeobox family of transcription factors. Members in this family are of ancient origin and play an important role in organ development during embryogenesis. A related mouse protein plays a role in patterning of inner ear structures. In humans, variations in a region containing this gene have been associated with inner ear malformations, vestibular dysfunction, and hearing loss.

Source: NCBI Gene 3167 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 48 total
  • MANE Select transcript: NM_005519

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:5018
Approved symbolHMX2
NameH6 family homeobox 2
Location10q26.13
Locus typegene with protein product
StatusApproved
AliasesNKX5-2
Ensembl geneENSG00000188816
Ensembl biotypeprotein_coding
OMIM600647
Entrez3167

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000339992

RefSeq mRNA: 1 — MANE Select: NM_005519 NM_005519

CCDS: CCDS31305

Canonical transcript exons

ENST00000339992 — 2 exons

ExonStartEnd
ENSE00001370710123149570123150672
ENSE00001448150123148136123148646

Expression profiles

Bgee: expression breadth broad, 28 present calls, max score 73.33.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1482 / max 61.3597, expressed in 22 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1074840.095215
1074850.03048
1074860.02268

Top tissues by expression

226 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
pancreatic ductal cellCL:000207973.33silver quality
buccal mucosa cellCL:000233670.21gold quality
tibialis anteriorUBERON:000138565.97silver quality
kidney epitheliumUBERON:000481965.12gold quality
adult mammalian kidneyUBERON:000008262.19gold quality
ileal mucosaUBERON:000033160.66gold quality
vena cavaUBERON:000408758.35gold quality
epithelial cell of pancreasCL:000008356.27gold quality
mucosa of transverse colonUBERON:000499155.75gold quality
kidneyUBERON:000211355.13gold quality
cardiac muscle of right atriumUBERON:000337954.34gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
upper arm skinUBERON:000426353.52gold quality
upper leg skinUBERON:000426251.25gold quality
myocardiumUBERON:000234950.25gold quality
lower lobe of lungUBERON:000894950.03silver quality
hypothalamusUBERON:000189849.63gold quality
quadriceps femorisUBERON:000137747.52gold quality
nasal cavity epitheliumUBERON:000538447.03gold quality
vastus lateralisUBERON:000137945.40gold quality
amniotic fluidUBERON:000017344.97gold quality
layer of synovial tissueUBERON:000761643.55gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
superior surface of tongueUBERON:000737142.79gold quality
lower esophagus mucosaUBERON:003583442.78silver quality
jejunumUBERON:000211542.73gold quality
cortex of kidneyUBERON:000122542.68gold quality
duodenumUBERON:000211442.63gold quality
secondary oocyteCL:000065542.57gold quality
skin of hipUBERON:000155442.50silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.65

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

1 targets.

TargetRegulation
SLC26A9

Upstream regulators (CollecTRI, top): HMX3, RBPJ

miRNA regulators (miRDB)

45 targeting HMX2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5692A100.0074.406850
HSA-MIR-3162-3P100.0065.37363
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-6870-5P99.9968.552115
HSA-MIR-548C-3P99.9974.017587
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-4723-5P99.9768.702034
HSA-MIR-569899.9768.492029
HSA-MIR-7111-5P99.9768.482062
HSA-MIR-493-5P99.9672.472382
HSA-MIR-101-3P99.9475.032230
HSA-MIR-132399.8369.892471
HSA-MIR-430799.8270.453374
HSA-MIR-129999.7771.242389
HSA-MIR-548O-3P99.7469.302228
HSA-MIR-4699-3P99.7170.153142
HSA-MIR-3934-5P99.6764.04846
HSA-MIR-46699.6770.852863
HSA-MIR-4690-5P99.6566.24813
HSA-MIR-4666B99.6468.691282
HSA-MIR-1260A99.6166.671098
HSA-MIR-1260B99.6166.671098
HSA-MIR-464399.4967.631791
HSA-MIR-5584-5P99.4968.222814
HSA-MIR-223-5P99.2468.821206
HSA-MIR-4717-3P99.0666.341072
HSA-MIR-3190-5P98.8764.891345

Literature-anchored findings (GeneRIF, showing 2)

  • propose that hemizygous deletions of HMX2 and HMX3 are responsible for inner ear malformations, vestibular dysfunction, and congenital sensorineural hearing loss (PMID:19253379)
  • Aberrant expression of NKL homeobox genes HMX2 and HMX3 interferes with cell differentiation in acute myeloid leukemia. (PMID:33048949)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriohmx2ENSDARG00000070954
mus_musculusHmx2ENSMUSG00000050100
rattus_norvegicusHmx2ENSRNOG00000020638

Paralogs (3): HOXA9 (ENSG00000078399), HMX3 (ENSG00000188620), HMX1 (ENSG00000215612)

Protein

Protein identifiers

Homeobox protein HMX2A2RU54 (reviewed: A2RU54)

Alternative names: Homeobox protein H6 family member 2

All UniProt accessions (1): A2RU54

UniProt curated annotations — full annotation on UniProt →

Function. Transcription factor involved in specification of neuronal cell types and which is required for inner ear and hypothalamus development.

Subcellular location. Nucleus.

Similarity. Belongs to the HMX homeobox family.

RefSeq proteins (1): NP_005510* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001356HDDomain
IPR009057Homeodomain-like_sfHomologous_superfamily
IPR017970Homeobox_CSConserved_site
IPR020479HD_metazoaDomain
IPR051300HMX_Homeobox_TFFamily

Pfam: PF00046

UniProt features (5 total): compositionally biased region 2, chain 1, DNA-binding region 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A2RU54-F165.510.24

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 80 (showing top): BENPORATH_ES_WITH_H3K27ME3, GOBP_POSITIVE_REGULATION_OF_RNA_SPLICING, GOBP_POSITIVE_REGULATION_OF_MRNA_PROCESSING, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_EAR_DEVELOPMENT, KOYAMA_SEMA3B_TARGETS_UP, GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS, GOBP_RNA_SPLICING, GOBP_EAR_MORPHOGENESIS, GOBP_HEAD_DEVELOPMENT, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME, GOBP_EMBRYO_DEVELOPMENT, GOBP_SENSORY_ORGAN_DEVELOPMENT, GOBP_SENSORY_ORGAN_MORPHOGENESIS

GO Biological Process (12): regulation of transcription by RNA polymerase II (GO:0006357), brain development (GO:0007420), cell differentiation (GO:0030154), inner ear morphogenesis (GO:0042472), positive regulation of mRNA splicing, via spliceosome (GO:0048026), epithelial cell proliferation (GO:0050673), positive regulation of epithelial cell proliferation (GO:0050679), stem cell proliferation (GO:0072089), positive regulation of stem cell proliferation (GO:2000648), regulation of DNA-templated transcription (GO:0006355), nervous system development (GO:0007399), cell population proliferation (GO:0008283)

GO Molecular Function (4): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677)

GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cell population proliferation2
positive regulation of cell population proliferation2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
central nervous system development1
animal organ development1
head development1
cellular developmental process1
ear morphogenesis1
embryonic morphogenesis1
inner ear development1
mRNA splicing, via spliceosome1
positive regulation of RNA splicing1
regulation of mRNA splicing, via spliceosome1
positive regulation of mRNA processing1
epithelial cell proliferation1
regulation of epithelial cell proliferation1
stem cell division1
stem cell proliferation1
regulation of stem cell proliferation1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
system development1
cellular process1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
double-stranded DNA binding1
sequence-specific DNA binding1
nucleic acid binding1
chromosome1
cellular anatomical structure1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

310 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
HMX2GALP22466687
HMX2PAX2Q02962617
HMX2GHRHP01286550
HMX2NXPH2O95156521
HMX2GRAMD1BQ3KR37480
HMX2BMP4P12644445
HMX2LRRC3BQ96PB8418
HMX2GJA9P57773395
HMX2ZNF560Q96MR9380
HMX2GJA10Q969M2366
HMX2CTNNB1P35222364
HMX2NALF2O75949360
HMX2CALYQ9NYX4332
HMX2BUB3O43684319
HMX2GZF1Q9H116315

IntAct

4 interactions, top by confidence:

ABTypeScore
STAMBPL1psi-mi:“MI:0914”(association)0.350
USP38psi-mi:“MI:0914”(association)0.350
HMX2CALB2psi-mi:“MI:0914”(association)0.350

BioGRID (6): LHPP (Affinity Capture-MS), CALB2 (Affinity Capture-MS), HMX2 (Affinity Capture-MS), HMX2 (Cross-Linking-MS (XL-MS)), HMX2 (Cross-Linking-MS (XL-MS)), HMX2 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0A1W2PQ73, A1YF16, A1YG93, A2RU54, A5PKG8, O02786, O14813, O15353, O35602, O43638, O57601, P13297, P19419, P28360, P35548, P41969, P42580, P43687, P49640, P50223, P50548, P52946, P52950, P63156, P63157, P70459, P78413, Q03358, Q14549, Q2VL78, Q2VL79, Q2VL82, Q2VL83, Q2VL84, Q2VL85, Q2VL86, Q2VL87, Q2VL88, Q5NSW5, Q61575

Diamond homologs: A1YF16, A1YG93, A2RU54, A2T764, A6NCS4, A6NHT5, G5EE18, M0R6D8, O02786, O35767, O42230, O57601, O60479, O70218, P10181, P13297, P15857, P19601, P20009, P23410, P28360, P28361, P28362, P35548, P35993, P40764, P42580, P42581, P43687, P43688, P48031, P50219, P50223, P50574, P50575, P50576, P50577, P52953, P53547, P53770

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

48 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance44
Likely benign3
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

325 predictions. Top by Δscore:

VariantEffectΔscore
10:123148558:G:GTdonor_gain1.0000
10:123148592:GGCCC:Gdonor_gain1.0000
10:123148593:GCCC:Gdonor_gain1.0000
10:123148559:A:Tdonor_gain0.9900
10:123148600:G:GTdonor_gain0.9900
10:123148601:G:GTdonor_gain0.9900
10:123148607:GGCCC:Gdonor_gain0.9900
10:123149560:C:Aacceptor_gain0.9900
10:123149566:TCA:Tacceptor_loss0.9900
10:123149567:CA:Cacceptor_loss0.9900
10:123149568:A:Gacceptor_loss0.9900
10:123149569:G:GCacceptor_loss0.9900
10:123148507:G:GTdonor_gain0.9800
10:123148645:GG:Gdonor_gain0.9800
10:123148646:GG:Gdonor_gain0.9800
10:123149568:A:AGacceptor_gain0.9800
10:123149569:G:GGacceptor_gain0.9800
10:123149569:GGT:Gacceptor_gain0.9800
10:123148596:C:CGdonor_gain0.9700
10:123148602:A:Tdonor_gain0.9700
10:123148643:CTGGG:Cdonor_loss0.9700
10:123148644:TGGG:Tdonor_loss0.9700
10:123148647:GT:Gdonor_loss0.9700
10:123148648:TAA:Tdonor_loss0.9700
10:123149568:AG:Aacceptor_gain0.9700
10:123149569:GG:Gacceptor_gain0.9700
10:123149569:GGTA:Gacceptor_gain0.9700
10:123148341:G:GTdonor_gain0.9500
10:123148538:G:GTdonor_gain0.9500
10:123148596:C:Gdonor_gain0.9500

AlphaMissense

1749 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:123149767:T:AF156I1.000
10:123149767:T:CF156L1.000
10:123149767:T:GF156V1.000
10:123149768:T:CF156S1.000
10:123149768:T:GF156C1.000
10:123149769:T:AF156L1.000
10:123149769:T:GF156L1.000
10:123149781:G:CQ160H1.000
10:123149781:G:TQ160H1.000
10:123149792:T:AL164H1.000
10:123149792:T:CL164P1.000
10:123149792:T:GL164R1.000
10:123149796:G:CE165D1.000
10:123149796:G:TE165D1.000
10:123149797:T:CS166P1.000
10:123149803:T:AF168I1.000
10:123149803:T:CF168L1.000
10:123149803:T:GF168V1.000
10:123149804:T:CF168S1.000
10:123149804:T:GF168C1.000
10:123149805:C:AF168L1.000
10:123149805:C:GF168L1.000
10:123149818:T:CY173H1.000
10:123149819:A:GY173C1.000
10:123149822:T:AL174Q1.000
10:123149836:C:AR179S1.000
10:123149846:T:CL182P1.000
10:123149849:C:AA183D1.000
10:123149858:T:CL186P1.000
10:123149864:T:AL188H1.000

dbSNP variants (sampled 300 via entrez): RS1001022112 (10:123150384 G>A), RS1001559774 (10:123150128 C>T), RS1001652693 (10:123148265 G>A,C), RS1001976564 (10:123149290 T>C), RS1002290976 (10:123147922 C>G), RS1002660096 (10:123147282 G>T), RS1002712614 (10:123147048 G>A), RS1004404254 (10:123146368 C>T), RS1004532803 (10:123150640 A>T), RS1004602520 (10:123149665 A>C,T), RS1004975484 (10:123150803 G>T), RS1005073336 (10:123150434 G>A), RS1005200290 (10:123148609 C>A), RS1005408077 (10:123147746 G>C), RS1005644373 (10:123148786 G>A)

Disease associations

OMIM: gene MIM:600647 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009391_677Metabolite levels6.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010506kynurenic acid measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
entinostatincreases expression, affects cotreatment2
belinostatincreases expression, affects cotreatment2
Valproic Acidincreases expression, increases methylation2
bisphenol Fincreases expression1
bisphenol Aincreases expression1
trichostatin Adecreases expression1
arseniteincreases methylation1
sodium arsenitedecreases expression1
tetrabromobisphenol Aincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
ICG 001decreases expression1
dorsomorphinaffects cotreatment, increases expression1
bisphenol Sincreases methylation, affects cotreatment1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Fulvestrantaffects cotreatment, increases methylation1
Vorinostataffects cotreatment, increases expression1
Panobinostataffects cotreatment, increases expression1
Benzo(a)pyreneincreases methylation, affects methylation1
Carbamazepineaffects expression1
Estradiolaffects expression1
Methotrexateincreases expression1
Niclosamideincreases expression1

Cellosaurus cell lines

2 cell lines: 2 embryonic stem cell

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_A2U4SEES3-1V human HMX2, clone1Embryonic stem cellMale
CVCL_A2U5SEES3-1V human HMX2, clone2Embryonic stem cellMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.